As of 2025-07-06, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is 0.10 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is 0.9%.
The range of the Relative Valuation is 0.10 - 0.10 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -4.4x - -4.4x | -4.4x |
| Fair Price | 0.10 - 0.10 | 0.10 |
| Upside | 0.9% - 0.9% | 0.9% |
| Date | P/E |
| 2025-07-03 | -4.36 |
| 2025-07-02 | -4.36 |
| 2025-06-30 | -4.14 |
| 2025-06-27 | -4.36 |
| 2025-06-26 | -4.36 |
| 2025-06-25 | -4.14 |
| 2025-06-24 | -4.36 |
| 2025-06-19 | -4.14 |
| 2025-06-11 | -4.80 |
| 2025-06-09 | -4.36 |
| 2025-06-06 | -5.01 |
| 2025-06-04 | -4.36 |
| 2025-06-03 | -4.36 |
| 2025-05-28 | -4.80 |
| 2025-05-21 | -4.58 |
| 2025-05-20 | -4.80 |
| 2025-05-16 | -4.58 |
| 2025-05-15 | -5.23 |
| 2025-05-14 | -4.58 |
| 2025-05-07 | -4.36 |
| 2025-05-06 | -4.36 |
| 2025-04-29 | -4.36 |
| 2025-04-28 | -5.23 |
| 2025-04-23 | -5.23 |
| 2025-04-21 | -5.01 |
| 2025-04-17 | -6.10 |
| 2025-04-16 | -4.80 |
| 2025-04-08 | -5.67 |
| 2025-04-07 | -5.23 |